Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation

被引:245
作者
Ma, Lei [1 ]
Seager, Matthew [1 ]
Wittmann, Marion [1 ]
Jacobson, Marlene [5 ]
Bickel, Denise [1 ]
Burno, Maryann [1 ]
Jones, Keith [1 ]
Graufelds, Valerie Kuzmick [1 ]
Xu, Guangping [1 ]
Pearson, Michelle [1 ]
McCampbell, Alexander [1 ]
Gaspar, Renee [2 ]
Shughrue, Paul [2 ]
Danziger, Andrew [2 ]
Regan, Christopher [2 ]
Flick, Rose [5 ]
Pascarella, Danette [5 ]
Garson, Susan [3 ]
Doran, Scott [3 ]
Kreatsoulas, Constantine [4 ]
Veng, Lone [2 ]
Lindsley, Craig W. [4 ]
Shipe, William [4 ]
Kuduk, Scott [4 ]
Sur, Cyrille [6 ]
Kinney, Gene [2 ]
Seabrook, Guy R. [1 ]
Ray, William J. [1 ]
机构
[1] Alzheimers Res, West Point, PA 19486 USA
[2] Integrat Syst Neurosci, West Point, PA 19486 USA
[3] Depress & Circadian Disorders, West Point, PA 19486 USA
[4] Med Chem, West Point, PA 19486 USA
[5] Schizophrenia Res, West Point, PA 19486 USA
[6] Imaging Merck Res Labs, West Point, PA 19486 USA
关键词
PROTEIN-COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; SEIZURE ACTIVITY; HIPPOCAMPUS; EXPRESSION; SUBTYPES; MICE; GENE; FEAR;
D O I
10.1073/pnas.0900903106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The forebrain cholinergic system promotes higher brain function in part by signaling through the M-1 muscarinic acetylcholine receptor (mAChR). During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M-1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses associated with non-selective muscarinic agonists. We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M-1 mAChR. BQCA reduces the concentration of ACh required to activate M-1 up to 129-fold with an inflection point value of 845 nM. No potentiation, agonism, or antagonism activity on other mAChRs is observed up to 100 mu M. Furthermore studies in M-1(-/-) mice demonstrates that BQCA requires M-1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain. Radioligand-binding assays, molecular modeling, and site-directed mutagenesis experiments indicate that BQCA acts at an allosteric site involving residues Y179 and W400. BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep. In contrast to M-1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces beta-arrestin recruitment to M-1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory. In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M-1 receptor and represents a promising therapeutic strategy for cognitive disorders.
引用
收藏
页码:15950 / 15955
页数:6
相关论文
共 42 条
[1]   Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development [J].
Austin, CP ;
Ky, B ;
Ma, L ;
Morris, JA ;
Shughrue, PJ .
NEUROSCIENCE, 2004, 124 (01) :3-10
[2]   Allosterism at muscarinic receptors: Ligands and mechanisms [J].
Birdsall, NJM ;
Lazareno, S .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) :523-543
[3]   Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].
Bodick, NC ;
Offen, WW ;
Levey, AI ;
Cutler, NR ;
Gauthier, SG ;
Satlin, A ;
Shannon, HE ;
Tollefson, GD ;
Rasmussen, K ;
Bymaster, FP ;
Hurley, DJ ;
Potter, WZ ;
Paul, SM .
ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473
[4]   Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity [J].
Bymaster, FP ;
Carter, PA ;
Yamada, M ;
Gomeza, J ;
Wess, J ;
Hamilton, SE ;
Nathanson, NM ;
McKinzie, DL ;
Felder, CC .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (07) :1403-1410
[5]   SUBSTITUTION OF 3 AMINO-ACIDS SWITCHES RECEPTOR SPECIFICITY OF G(Q)ALPHA TO THAT OF G(I)ALPHA [J].
CONKLIN, BR ;
FARFEL, Z ;
LUSTIG, KD ;
JULIUS, D ;
BOURNE, HR .
NATURE, 1993, 363 (6426) :274-276
[6]   Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization [J].
Elhusseiny, A ;
Cohen, Z ;
Olivier, A ;
Stanimirovic, DB ;
Hamel, E .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (07) :794-802
[7]   MUSCARINIC ACETYLCHOLINE-RECEPTORS - SIGNAL-TRANSDUCTION THROUGH MULTIPLE EFFECTORS [J].
FELDER, CC .
FASEB JOURNAL, 1995, 9 (08) :619-625
[8]   Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease [J].
Fisher, Abraham .
NEUROTHERAPEUTICS, 2008, 5 (03) :433-442
[9]   The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints [J].
Fredriksson, R ;
Lagerström, MC ;
Lundin, LG ;
Schiöth, HB .
MOLECULAR PHARMACOLOGY, 2003, 63 (06) :1256-1272
[10]   Abnormalities of neural circuitry in Alzheimer's disease - Hippocampus and cortical cholinergic innervation [J].
Geula, C .
NEUROLOGY, 1998, 51 (01) :S18-S29